Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Here are latest arrivals approved by the Food and Drug Administration.
A dedicated student of jiujitsu, Avie Barron, 36, was diagnosed with non-Hodgkin lymphoma in her right lung.
The agency also announced the qualification of a tool to aid in the effectiveness assessment of devices used in breast reconstruction.
Lymphoma is a cancer that begins in the cells of the lymph system.
World Lymphoma Awareness Day (WLAD) is held on September 15 every year and is a day dedicated to raising awareness of lymphoma.
Here’s a list of the approved drugs to treat lyphoma including Non-Hodgkin lymphoma and Hodgkin lymphoma. Click on any of the medicat...
More than a third of people treated with Monjuvi plus Revlimid experienced complete remission.
Tecartus led to durable remission in a majority of participants in a Phase II study.
KTE-X19 led to durable remission in a majority of study participants.
After Erica Campbell was diagnosed with Stage IV Hodgkin lymphoma, she could barely stand. Now she’s walking runways as a plus-size model.
The SADAL study showed a 29% response rate for treatment-experienced people with DLBCL.
A study showed a 69% response rate for patients whose cancer carries the targeted mutation.
September was designated as National Blood Cancer Awareness Month in 2010 by United States Congress.
David Fajgenbaum, MD, crowdsourced treatment for the lymphoma-like Castleman disease. His research may help find new drugs for COVID-19.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.